A botanical extract (Regrapex-R ® ) prepared from whole grape (Vitis vinifera) and Polygonum cuspidatum, which contains polyphenols, including flavans, anthocyanins, emodin, and resveratrol, exhibited dose-dependent scavenging effects on reactive oxygen species (ROS). The extract inhibited increases of ROS and protein carbonyl in isolated rat liver mitochondria following exposure to 2,2Ј-azobis (2-amidino propane) dihydrocholoride (AAPH), a potent lipid oxidant generator. The antioxidant effects of this extract were further demonstrated by protecting enzyme activities of the mitochondrial respiratory electron transport chain (complexes I and II) and pyruvate dehydrogenase in isolated liver mitochondria with AAPH insult. In human neuroblastoma cells (SK-N-MC), pretreatment of extract protected cells against AAPH induced oxidation in maintaining cell viability and inhibiting excessive ROS generation. Extract was fed to transgenic Drosophila expressing human ␣-synuclein. This model for Parkinson disease recapitulates essential features of the disorder, including loss of dopaminergic neurons in the substantia nigra and a locomotor dysfunction that is displayed by a progressive loss of climbing ability measured using a geotaxis assay. Male transgenic flies fed the extract (0.16-0.64 mg/100 g of culture medium) showed a significant improvement in climbing ability compared to controls. Female transgenic flies showed a significant extension in average lifespan. These results suggest that Regrapex-R is a potent free radical scavenger, a mitochondrial protector, and a candidate for further studies to assess its ability to protect against neurodegenerative disease and potentially extend lifespan.
Introduction

T HE HEALTH BENEFITS OF CONSUMING GRAPES (Vitis vinifera)
and grape seed extract (GSE) have been widely reported, and products based on such extracts are available worldwide. In Europe and Asia, botanical extracts are often consumed as phytomedicines, whereas in the United States such products are marketed and sold as dietary supplements. Approximately 62% of U.S. adults are using some form of complementary and alternative medical approach for preventing and managing chronic disease and consumption of botanical extracts, comprising a large part of this practice; however, the health claims of such products remain largely unsubstantiated. 1 The health benefits attributed to the polyphenols in grape extract are wide ranging and include evidence of cardioprotective effects, [2] [3] [4] including reducing the incidence of atherosclerosis 5, 6 and protecting against hypertension in animal models 7, 8 ; anticancer effects including colon cancer, 9 prostate cancer, 10 and oral squamous carcinomas 11 ; and neurodegenerative diseases like Alzheimer disease. 12, 13 In the case of neurodegenerative disease, it has been suggested that GSE exerts its effects through changes in the levels of specific brain proteins that may be responsible for the neuroprotective effects observed. 14 Extracts of grape and GSE are rich in polyphenols, including several bioactive chemical classes, primarily the proanthocyanidins, which are a mixture of procyanidin derivatives of the flavan-3-ol class of flavonoids. This class includes catechin and epicatechin as dimers and oligomers, including their gallic acid esters. GSE proanthocyanidins comprise approximately 60-70% of the polyphenol content of grapes. 15, 16 The primary health benefits of grape extract are believed to be due to its well-documented and potent antioxidant properties, which provide excellent protection against oxidative stress and free radical-mediated tissue injury. 17 Grape extract has been shown to be highly bioavailable and provides significantly greater protection against free radicals and free radical-induced lipid peroxidation and DNA damage than vitamins C, E, and ␤-carotene.
However, the effects of grape extract on mitochondria and Parkinson disease (PD) have not been well studied. The present study evaluated the antioxidant effects of a wellcharacterized grape extract preparation (Regrapex-R ® ) using both in vitro and in vivo assays. The results demonstrated Regrapex-R enhanced rat liver mitochondrial enzyme complexes and ameliorated the locomotor dysfunction that were exhibited by the ␣-synuclein transgenic Drosophila model for PD, in addition to its free radical scavenging activity.
Materials and Methods
Chemicals
Tris base and nicotinamide adenine dinucleotide (NADH) were purchased from Amersco Inc. (Palm Harbor, FL); 2,6-dichloroindophenol indophenol (DCPIP) from Merck & Co. Inc. (USA); rotenone from Riedel De Haen Seelze (Hannover, Germany); 5,5-dimethyl-1-pyrroline N-oxide (DMPO), 2-(4-pyridyl-1-oxide)-N-t-butylnitrone (POBN), coenzyme Q1, antimycine A, p-iodonitrotetrazolium violet (INT), dithiothreitol, and thiamin pyrophosphate from Sigma Chemical Co. (St. Louis, MO); and 2,2Ј-azobis (2-amidino propane) dihydrocholoride (AAPH) from Wako Pure Chemical Industries, Ltd. Dichlorofluorescein diacetate (DCF-DA) was purchased from Molecular Probes (Eugene, OR), and the BCA Protein Assay kit for protein quantification was from Pierce (Pierce Biotechnology, Inc., Milwaukee, WI). Other chemicals were all A.P. reagents from local vendors.
Grape extract
A grape extract fortified with resveratrol commercially available as a dietary supplement was obtained from Biophysica Inc. (San Diego, CA). 18 Regrapex-R, manufactured by Interpharma Praha (Praha 12-Modrany, Czech Republic), contains a whole-grape (Vitis vinifera) extract enriched with purified powdered extract from dried roots of Polygonum cuspidatum (1 gram of bulk consists of 800 mg of whole grape extract and 200 mg of dried root powder from P. cuspidatum). One gram of Regrapex-R contains 100 mg of resveratrol complex (trans-resveratrol and its glycosides), 10 mg of emodin complex (emodin and emodin glycosides), 450 mg of polyphenols, and 12 mg of anthocyanins.
Grape extract solution preparation
A stock solution was prepared with water for electron spin resonance (ESR) assay of hydroxyl radical or with dimethylsulfoxide (DMSO) for other assays.
Free radical scavenging
Hydroxyl radical, superoxide radical, and lipid radicals were detected using spin trapping agents with an ESR spectrometer. [19] [20] [21] Briefly, hydroxyl radical was detected in a 50-L reaction mixture containing 100 mM DMPO, 100 mM hydrogen peroxide (H 2 O 2 ), 0.3 mM Fe (II)/0.15 mM diethylene triamine pentaacetic acid (DTPA), and 30 L of sample. The reaction was initiated by 0.3 mM Fe(II)/0.15 mM DTPA, and then ESR spectra were recorded 5 min after the start of the reaction. Lipid radical was detected in a 50-L reaction mixture containing 100 mM POBN, 20 mM sodium dodecyl sulfate (SDS), 40 mM linoleic acid (LA), 0.11 mM Cu 2ϩ , 0.1 M H 2 O 2 , 20 mM phosphate-buffered saline (PBS), and 20 L of sample. The reaction was initiated by Cu 2ϩ , and ESR spectra were recorded 5 min after Cu 2ϩ addition. For superoxide, ESR spectra were obtained in the reaction mixture containing 0.33 mM hypoxanthine, 0.83 mM DTPA, 0.15 M DMPO, 0.083 U/mL xanthine oxidase, and a 20-L sample. Spectra were measured 3 min after addition of xanthine oxidase (XOD) to initiate the reaction.
Mitochondrial preparation
Male Sprague-Dawley rats (180-200 grams) were purchased from Shanghai SLAC Laboratory Animal Co. Ltd (Shanghai, China). The animals were killed by decapitation after an overnight fast, and their livers were removed for immediate isolation of mitochondria. Mitochondria were isolated as described 22 with slight modification. Briefly, tissues were rinsed with saline, weighed, and put into ice-cold isolation buffer containing 0.25 mM sucrose, 10 mM Tris, 0.5 mM ethylenediaminetetraacetic acid (EDTA), pH 7.4. Tissues were carefully minced and rinsed to remove residual blood, and then homogenized in 2.5 volumes of isolation buffer. The homogenate was adjusted to 8 volumes with isolation buffer and centrifuged at 1,000 ϫ g for 10 min; the resultant supernatant fraction was decanted and saved, the pellet was washed once with 2 volumes of isolation buffer. The supernatant obtained after 1,000 ϫ g centrifugation was combined and centrifuged at 10,000 ϫ g for 10 min. The mitochondria in the pellet obtained by the 10,000 ϫ g centrifiguation was resuspended with isolation buffer followed by being washed twice with the buffer. All of the above operations were carried out at 4°C. The mitochondrial protein was determined by the BCA Protein Assay kit with bovine serum albumin (BSA) as the standard. Fresh mitochondria were either used immediately for reactive oxygen species (ROS) and mitochondrial potential assays, or stored at Ϫ80°C until enzyme analysis.
ROS assay with DCF-DA in isolated rat liver mitochondria ROS was assayed as described. 23 In brief, 0.25 mg of isolated liver mitochondria were added to 500 L of isolation buffer with 5 mM AAPH, 5 mM pyruvate, and 10 M DCF-DA, and then incubated with or without extract (final concentration 1, 5, 10, 20 g/mL Regrapex-R) for 30 min at 37°C. ROS generation was recorded fluorimetrically for 30 min with an excitation wavelength of 488 nm and an emission wavelength 525 nm by fluorometer (Flex Station II 384, Molecular Device).
Mitochondrial enzyme activity assays
For all enzyme assays, mitochondria (500 g/mL) were dissolved in different buffers (indicated under specific enzyme assay) and exposed to a certain concentration of AAPH for 30 min or 60 min with or without the presence of Regrapex-R at 37°C. Mitochondria were then harvested for enzyme assay. NADH-CoQ oxidoreductase (complex I) activity was assayed by monitoring the reduction of DCPIP at 600 nm upon addition of assay buffer (10ϫ buffer containing 0.5 M Tris-HCl , pH 8.1, 1% BSA, 10 M antimycin A, 2 mM NaN 3 , 0.5 mM coenzyme Q1). The final concentration of mitochondria protein was 25 g/mL. The reaction was started by adding 200 M NADH and scanned at 600 nm for 2 min. Assays of succinate-CoQ oxidoreductase (complex II) were performed as described. 24, 25 Briefly, complex II was assayed in the assay buffer (10ϫ buffer contain 0.5 M phosphate buffer, pH 7.8, 1% BSA, 10 M antimycin A, 2 mM NaN 3 , 0.5 mM coenzyme Q1) with mitochondria (final concentration 25 g/mL). The reaction was started with 10 mM succinate and scanned at 600 nm for 2 min at 30°C. The pyruvate dehydrogenase (PDH) assay was carried out according to the Hinman method. 26 Briefly, the AAPH-reacted mitochondrial suspension was placed in an assay buffer containing 2.5 mM NAD ϩ , 0.1 mM coenzyme A, 0.2 mM TPP, 1 mM MgCl 2 , 1 mg/ml BSA, 0.05 M TrisHCl buffer, pH 7.8, 0.6 mM INT,and 0.1 mg/mL lipoamide dehydrogenase.The reaction was started with 5 mM pyruvate and 0.3 mM dithiothreitol, then scanned at 500 nm for 2 min. All assays were performed at 30°C.
Protein carbonyl assay in isolated rat liver mitochondria
Liver mitochondria were treated with 1 mM AAPH for 30 min at 37°C with or without extract. Protein carbonyls in mitochondria were assayed with the Oxyblot protein oxidation detection kit (Chemicon, Purchase, CA), followiong the kit guide. The carbonyl groups in the protein side chains were derivatized to 2,4,-dinitrophenylhydrazone (DNP-hydrazone) by reaction with 2, 4-dinitrophenylhydrazine (DNPH). The DNP-derivatized protein samples were separated by polyacrylamide gel electrophoresis followed by western blotting. Additional polyacrylamide resolving gels (12%, wt/vol) loaded with the same quantity of samples were electrophoresed and stained with Coomassie Brilliant Blue R250 as the loading control.
Cell viability and ROS generation in SK-N-MC cells
SK-N-MC cells were grown (Corning Glass, Corning, NY) in minimal essential medium (MEM) in a 96-well plate with 10% fetal bovine serum at 5% CO 2 and 37°C. When cells grew to 80% confluence, extract was added in serum-free medium and the cells were cultured for 24 h. Cells were then washed and exposed to 15 mM AAPH 1 h before further assays. After exposure to AAPH, cells were washed once with PBS. Cell viability was measured by the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. The ROS assay was performed as follows: Cells were incubated with 10 M DCF-DA for 15 min, and the kinetic curve of ROS generation was recorded fluorimetrically for 30 min with an excitation wavelength of 488 nm and an emission wavelength 525 nm by fluorometer (Flex Station II 384, Molecular Device).
Drosophila culture
Transgenic ␣-synuclein Drosophila were obtained from Dr. Feany at Harvard University. 28 The Parkinson model flies express ␣-synuclein and produce adult-onset loss of dopaminergic neurons, filamentous intraneuronal inclusions containing ␣-synuclein, and locomotor dysfunction. The control non-PD flies (UAS-wild-type ␣-synuclein/ϩ) and PD flies (Ddc-GAL4/ϩ; UAS-wild-type ␣-synuclein/ϩ) were maintained at 25°C on a 12-h light/dark cycle in bottles containing agar, corn meal, sucrose, water, and dried yeast medium. Propionic acid was added to prevent fungal growth. Extract was added to the medium at the final concentrations (0.08-0.64 mg/100 grams of culture) marked in the result, e.g., PDϩ0.08 representing flies of PD model fed with medium containing 0.08 mg extract/100 grams. UAS-wild-type ␣-synuclein flies were used as the basis for comparison with the PD flies because they were the female parent of PD flies and a genetically steady, constant breeding stock whose functional behavior in our standard locomotor assay described below was identical with the transgenic stock during the first 6 or 12 days after eclosion.
Drosophila climbing (negative geotaxis) assay
The climbing assay was performed as described. 29 Ten flies were placed in an empty vitreous 110-ϫ 27-mm vial; a horizontal line was drawn 80 mm above the bottom of the vial. After the flies had acclimated for 10 min at room temperature, every group was assayed at random, to a total of 10 trials for each. The procedure involved gently tapping the flies down to the bottom of the vial. The number of flies above the mark of the vial was counted after 10 s of climbing and was repeated for 10 times to get the mean number above the mark of flies in this vial. These values were then averaged, and a group mean and standard error were obtained. The resulting mean was used as the overall value, that is to say exponent of climbing ability to be discussed for each single group of flies on a particular day. Where appropriate, the mean values of various fly groups were statistically compared using an unpaired group of the Student t-test. All behavioral studies were performed in an isolation room at 25°C, 60-70% humidity under standard lighting conditions.
Drosophila lifespan determination
Flasks containing the desired stocks were emptied, leaving pupa to emerge (eclose) as adults. Newly eclosed flies of both the non-PD control and PD strains were placed in culture tubes (10 flies per tube) that contained Regrapex-R-treated food, which was renewed every 3 days. Control organisms were treated similarly, except that the medium was extract free. The following day, the number of dead flies was recorded at 3-day intervals until the last one died. 
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Statistical analyses
Data of in vitro assays were represented as mean Ϯ SD of three independent experiments, and each experiment was performed in triplicate. A significant difference was calculated by using the Student t-test between the control and the AAPH model, and by using one-way analysis of variance (ANOVA) with the Dunnett multiple comparison test between the AAPH model and Regrapex-R-treated groups. Data of fly locomotion assays are shown as mean Ϯ SD. Statistical comparisons were performed by using one-way ANOVA and post hoc significance testing with the Dunnett multiple comparison test. The lifespan of the flies was analyzed using log rank test, and p Ͻ 0.05 was considered statistically significant.
Results
Regrapex-R effects on free radical scavenging
Regrapex-R showed a dose-dependent scavenging effect on hydroxyl radical (Fig. 1a,b) , superoxide radical (Fig.  1c,d) , and lipid radical (Fig. 1e,f) . The 50% free radical scavenging concentrations (half-maximal inhibitory concentration, IC 50 ) of the extract are 24.6, 0.0026, and 3.68 mg/mL for hydroxyl, superoxide, and lipid radicals, respectively. The free radical scavenging effects were compared with some well-known and specific scavengers, as shown in Table 1 . The IC 50 of Regrapex-R for hydroxyl and lipid radicals are at a similar level to those of EPC-K1, a well-known For the enzymes assay, isolated rat liver mitochondria (0.5 mg/mL) were incubated with various concentrations of Regrapex-R followed by 5 mM AAPH (for PDH), 10 mM AAPH (for complex I), or 15 mM AAPH (for complex II) exposure at 37°C for 60 min (for complex I) or 30 min (for complex II, PDH). The complex activity was measured by scanning the samples in the reaction buffers with a microplate reader at 600 nm for 2 min, and PDH activity was measured at 500 nm for 2 min as described in Materials and Methods. All values are mean Ϯ SD of three independent experiments of three replicates each. Asterisk shows significant differences between control and AAPH model using the Student t-test (*) p Ͻ 0.05). (#) Significant difference between AAPH and Regrapex-R-treated AAPH mitochondria using one-way analysis of variance (ANOVA) with the Dunnett multiple comparison test; (#) p Ͻ 0.05. Hydroxyl, superoxide, and lipid radicals were detected using spin trapping agents with ESR spectrometer. The half-maximal inhibitory concentrations (IC 50 ) of the extract and other scavengers were calculated by linear regression of log-dose versus radical yields.
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EPC-K1, Free radical scavenger and antioxidant constituted by vitamins E and C; ESR, electron spin resonance.
free radical scavenger and antioxidant constituted by vitamins E and C, 30,31 while 9,038-fold more potent than EPC-K1 for superoxide radical. Regrapex-R was about 653-fold more potent for superoxide radical scavenging, compared with resveratrol, 32 a caloric restriction mimetic agent able to extend the lifespan of Drosophila. 33 Regrapex-R was 2-fold more potent for lipid radical scavenging when compared with ␣-tocopherol. 
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Effect of Regrapex-R on AAPH-induced ROS generation in isolated liver mitochondria
We tested the protective effects of Regrapex-R on AAPH, a lipid-like oxidant generator that induced mitochondrial damage in isolated rat liver mitochondria. As shown in Fig.  2 , AAPH greatly increased ROS generation, and Regrapex-R demonstrated a dose-dependent inhibition on AAPH-induced ROS increase in the liver mitochondria at the dose range of 1-100 g/mL.
Effect of Regrapex-R on AAPH-induced inactivation of mitochondrial enzymes in isolated liver mitochondria
As shown in Fig. 2 , mitochondrial complex I lost about 30% activity following exposure to 10 mM AAPH for 1 h. Regrapex-R showed a protective effect at the concentrations of 0.1-50 g/mL. Similarly, mitochondrial complex II lost 50% activity in the insult of 15 mM AAPH for 30 min, and pretreatment of Regrapex-R at the range of 5-50 g/mL showed significant protection against AAPH-induced damage (Fig. 2) . As for PDH, a key dehydrogenase located in mitochondria, Regrapex-R, also showed a dose-dependent protection at the dose range of 5-50 g/mL (Fig. 2) .
Effect of Regrapex-R on AAPH-induced protein oxidation in isolated liver mitochondria
As shown in Fig. 3 , AAPH insult resulted in a significant increase of protein carbonyl in liver mitochondria, which can be remarkably attenuated by Regrapex-R in a dose-dependent manner at 1 g/mL to 100 g/mL (Fig. 3) .
Effect of Regrapex-R on cell viability and ROS in SK-N-MC cells
SK-N-MC cell viability showed a 15% decrease when cells were challenged with AAPH (15 mM) for 1 h (Fig. 4) , and pretreatment with 5-20 g/mL Regrapex-R for 24 h completely protected cells against oxidative insult. However, the protective effect disappeared at the higher Regrapex-R concentration of 50 g/mL (Fig. 4) . AAPH-induced (15 mM for 1 h) ROS generation was greatly elevated to 5.5-fold higher than that of control cells without insult, and Regrapex-R significantly inhibited the AAPH-induced ROS generation at the concentration Ն10 g/mL (Fig. 4) .
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Regrapex-R effects on the climbing activity and life span of Drosophila PD model
As shown in Fig. 5 , the climbing response of the non-PD and PD flies (Fig. 5a, male; Fig. 5b , female) decreased progressively with age. However, the climbing response of the male PD flies was significantly lower than those of the non-PD flies at the age range of 3 days to 42 days (vs. non-PD, p Ͻ 0.05), and female PD flies showed a similar decline of locomotion at the age range of 6 days to 42 days compared with non-PD control (vs. non-PD, p Ͻ 0.05). Regrapex-R was mixed in the culture of the test groups of transgenic flies at the concentrations of 0.08-0.64 mg/100 grams of culture medium (corn medium). These levels were selected on the basis of previous studies indicating that they were effective but not toxic and nonlethal. Noticeably, at the concentration range of 0.16-0.64 mg/100 grams of culture medium as shown in Fig. 5a , Regrapex-R significantly improved the climbing response in male PD flies at the age range from 18 days up to 42 days (vs. PD without treatment, p Ͻ 0.05). However, no consecutive significant differences between PD and Regrapex-R-treated PD female flies were observed.
As for lifespan evaluation in male flies (Fig. 6a) , transgenic PD flies showed a shorter lifespan than that of con- trol ␣-synuclein flies (vs. non-PD, p Ͻ 0.01). Among four doses of Regrapex-R treatments, one dose at 0.64 mg/100 grams of culture significantly extended lifespan of PD male flies (vs. PD without treatment, p Ͻ 0.05). In contrast to the effect on male PD flies, Regrapex-R did no improve the climbing response in female flies; however, as shown in Fig.  6b , Regrapex-R exhibited an effect on extending the average lifespan in female PD flies at the doses from 0.16 mg to 0.64 mg/100 grams of medium (vs. PD without treatment, p Ͻ 0.05).
Discussion
Our data showed that Regrapex-R, a combination botanical formulation comprised of an extract of whole grape (Vitis vinifera) and Polygonum cuspidatum possesses potent antioxidant activity, protects mitochondria from oxidative damage, and is an effective agent in ameliorating the loss of locomotor function in a Drosophila model for PD. We believe this is the first study to demonstrate a direct neuroprotective effect of a grape-based extract in a genetic model of PD.
PD, the second most common neurodegenerative disorder after Alzheimer disease, is characterized by several abnormalities, including inflammation, mitochondrial dysfunction, iron accumulation, and oxidative stress. Many pharmaceutical intervention strategies are targeted to one or more of these abnormalities by focusing on the molecular pathways underlying the dysfunction and the role that these pathways may play in disease initiation and progression. Most therapeutic strategies currently rely on providing protection against the massive degenerative loss of dopamine neurons, particularly in the substantia nigra. Whereas classic therapy relies on administration of levodopa, the efficacy of this agent declines as PD progresses. Newer strategies aimed at rescue of nigral dopamine neurons from progressive cell death are currently being explored. One pathway target of primary interest and explored in this study is oxidative stress, a dysfunction that can be reduced by agents with potent free radical scavenging capabilities.
The results of our free radical scavenging experiments agree with previous reports of the potent antioxidant activity associated with polyphenols found in grape extracts. 34 However, we observed particularly potent activity against the superoxide radical where Regrapex-R was 653-fold more potent than resveratrol and Ͼ9,000 fold more potent than EPC-K1, a combination of ␣-tocopherol and ascorbic acid.
It is well documented that mitochondria are the major source of intracellular ROS concomitant with the oxygen phosphoralytion. The major single-organ oxygen consumers are the liver and brain, consuming 20.4% and 18.4%, respectively. In our previous in vitro study, we found that the endogenous ROS (RFU/mg of protein fluorescently detected with DCF-DA) in freshly isolated murine liver mitochondria exhibit a 30 times higher level than that in brain mitochondria and also showed significant vulnerability to external oxidatative insults, such as AAPH, H 2 O 2 , etc. (unpublished). Therefore, the liver mitochondria can be served as an optimal subcellular system to evaluate the antioxidative capacity of the potential antioxidants. In the current study, following the evaluation of the specific activity to scanvenging hydroxyl radicals, lipid radicals and superoxides by ESR assays, the impact of antioxidative activity on the biological effect was investigated in isolated rat liver mitochondria with AAPH insult. We indeed observed a protective effect of the extract against oxidative damage by AAPH on maintaining activities of mitochondrial enzymes (complexes I and II and PDH), suppressing excessive ROS and resisting protein oxidative modification. The antioxidative benefits of the extract were further verified on human SK-N-MC neuroblastoma cells, which retain cell viability and have a lower level of ROS than vehicle-treated cells following exposure to the toxin.
Oxidative stress has been hypothesized to be linked to both the initiation and the progression of PD. 13 Genetic mutation of ␣-synuclein, a major component of Lewy bodies in sporadic PD, may increase neuronal vulnerability to cellular oxidative stress in PD pathogenesis. 32 In that potent antioxidant capacity of the extract as we investigated the in vitro system, we evaluated the potential effects of grape extract on the locomotion and lifespan of genetic Drosophila model of PD developed by Feany and Bender in 2000. 28 In this model, normal and mutant forms of ␣-synuclein were expressed in Drosophila, producing adult-onset loss of dopaminergic neurons and filamentous intraneuronal inclusions containing ␣-synuclein with consequent locomotor dysfunction. A recent proteomic analysis of this panneural expression of human wild type (WT) ␣-synuclein in the transgenic flies showed a differential expression of proteins indicating a perturbation of molecular pathways involving metabolism and signaling. 35 Gene expression changes for genes in these molecular pathways have been shown to be greatest in this model at the presymptomatic stage, when the potential for neuroprotection is greatest, thus validating this model for identifying potential targets for neuroprotective strategies. 36 A relatively straightforward negative geotaxis assay can be performed to determine whether or not a variety of compounds or drugs incorporated into fly food prevent the progressive loss of climbing ability of the ␣-synuclein transgenic flies.
Our results showed a significant improvement in the climbing response of PD flies at a Regrapex-R dose range of 0.16-0.64 mg/100 grams of culture medium. This effect was also demonstrated to show a gender bias because only male flies fed grape extract showed an improvement in climbing, whereas female flies did not. These results, taken together, suggest that grape extract fortified with resveratrol may exert its neuroprotective effect through prevention of oxidative damage via potent ROS scavenging ability.
Grape extract extended the average lifespan of female PD flies at the concentration 0.64 mg/100 grams of culture medium. This effect, like that observed in the climbing assay, also showed a gender bias with no extension of lifespan observed in the male PD flies (except of 0.64 mg/100 grams treatment). Specific metabolic signaling pathways and differentiated gene expression in different genders may be involved in those sex-specific protective effects in flies. [37] [38] [39] [40] Further investigation will be directed at revealing this interesting phenomenon.
There is a great deal of interest in identifying agents that have an effect on aging. Notably, resveratrol, an enriched component of the Regrapex-R formulation and a common component of grapes, has been demonstrated to extend lifespan in a variety of organisms, including yeast, nematodes, and Drosophila. 33 Our results are consistent with these findings, but suggest that grape polyphenols should be the focus of further research in this area because a direct effect of grape polyphenols alone on lifespan extension has not yet been demonstrated.
Results from these studies contribute to our understanding of the role of polyphenols in protecting against neurodegenerative disease. The data suggest that polyphenols exert their protective effects in a manner consistent with the most recent proposed mechanisms underlying the pathogenesis of PD. Regrapex-R and similar polyphenol-rich combination botanical products should be further evaluated as therapeutic strategies aimed at prevention and treatment of neurodegenerative diseases.
